Biomarin Pharmaceutical Inc BMRN:NASDAQ

Last Price$79.28NASDAQ Closing Price as of 4:00PM ET 5/19/22

Today's Change+1.10(1.41%)
Bid (Size)$74.44 (2)
Ask (Size)$86.50 (1)
Day Low / High$78.11 - 80.36
Volume852.2 K
 

View Biotechnology IndustryPeer Comparison as of 05/19/2022

 

Biomarin Pharmaceutical Inc ( NASDAQ )

Price: $79.28
Change: +1.10 (1.41%)
Volume: 852.2 K
4:00PM ET 5/19/2022
 
 

Bio-Techne Corp ( NASDAQ )

Price: $366.44
Change: +7.35 (2.05%)
Volume: 208.7 K
4:00PM ET 5/19/2022
 
 

N/A ( N/A )

Price: N/A
Change: N/A N/A
Volume: N/A
N/A
 
 

Exact Sciences Corp ( NASDAQ )

Price: $54.00
Change: +2.00 (3.85%)
Volume: 2.7 M
4:00PM ET 5/19/2022
 
 

Neurocrine Biosciences Inc ( NASDAQ )

Price: $85.37
Change: +0.42 (0.49%)
Volume: 624.0 K
4:00PM ET 5/19/2022
 

Read more news Recent News

Insider Sell: BioMarin Pharmaceutical
1:32PM ET 5/04/2022 MT Newswires

George Eric Davis, Executive Vice President, Chief Legal Officer, on April 29, 2022, sold 15,347 shares in BioMarin Pharmaceutical (BMRN) for $1,233,592....

Insider Sell: BioMarin Pharmaceutical
1:30PM ET 5/04/2022 MT Newswires

Richard A Meier, Director, on May 02, 2022, sold 3,878 shares in BioMarin Pharmaceutical (BMRN) for $318,345. Following the Form 4 filing with the SEC,...

Insider Sell: BioMarin Pharmaceutical
9:53AM ET 5/03/2022 MT Newswires

Jean Jacques Bienaime, Director, Chief Executive Officer, on April 28, 2022, sold 25,000 shares in BioMarin Pharmaceutical (BMRN) for $2,085,550. Following...

--Oppenheimer Adjusts BioMarin Pharmaceutical Price Target to $94 From $95, Maintains Perform Rating
11:22AM ET 4/28/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

Company Profile

Business DescriptionBioMarin Pharmaceutical, Inc. engages in the development and commercialization of therapies for people with serious and life-threatening rare diseases and medical conditions. Its pipeline products include Valoctocogene roxaparvovec, Vosoritide, and BMN 307. The company was founded by John C. Klock, Christopher M. Starr and Grant W. Denison on March 21, 1997, and is headquartered in San Rafael, CA. View company web site for more details
Address770 Lindaro Street
San Rafael, California 94901
Phone+1.415.506.6700
Number of Employees2,849
Recent SEC Filing05/18/20224
Chairman & Chief Executive OfficerJean-Jacques Bienaimé
Chief Financial Officer & Executive VP-FinanceBrian R. Mueller
Chief Information OfficerEduardo E. von Pervieux
President-Worldwide Research & DevelopmentHenry J. Fuchs

Company Highlights

Price Open$78.40
Previous Close$78.18
52 Week Range$71.59 - 94.20
Market Capitalization$14.7 B
Shares Outstanding185.0 M
SectorHealth Technology
IndustryBiotechnology
Next Earnings Announcement07/27/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / Earnings431.83
Earnings per Share$0.21
Beta vs. S&P 500N/A
Revenue$1.5 B
Net Profit Margin2.10%
Return on Equity0.92%

Analyst Ratings as of 04/25/2022

Buy
16
Overweight
4
Hold
2
Underweight
0
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset